• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Invasive breast cancer.

作者信息

Carlson Robert W, Anderson Benjamin O, Burstein Harold J, Carter W Bradford, Edge Stephen B, Farrar William B, Goldstein Lori J, Gradishar William J, Hayes Daniel F, Hudis Clifford A, Jahanzeb Mohammad, Ljung Britt-Marie, Kiel Krystyna, Marks Lawrence B, McCormick Beryl, Nabell Lisle M, Pierce Lori J, Reed Elizabeth C, Silver Samuel M, Smith Mary Lou, Somlo George, Theriault Richard L, Ward John H, Winer Eric P, Wolff Antonio C

机构信息

National Comprehensive Cancer Network

出版信息

J Natl Compr Canc Netw. 2007 Mar;5(3):246-312. doi: 10.6004/jnccn.2007.0025.

DOI:10.6004/jnccn.2007.0025
PMID:17439758
Abstract
摘要

相似文献

1
Invasive breast cancer.浸润性乳腺癌。
J Natl Compr Canc Netw. 2007 Mar;5(3):246-312. doi: 10.6004/jnccn.2007.0025.
2
Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.与乳腺浸润性导管癌相比，I期和II期乳腺浸润性小叶癌保乳治疗的长期结果相似：宾夕法尼亚大学的经验。
Cancer. 2005 Jun 15;103(12):2447-54. doi: 10.1002/cncr.21071.
3
[1st revision of the National Consensus on Breast Cancer Treatment].[《乳腺癌治疗国家共识》第一次修订版]
Ginecol Obstet Mex. 2002 Jul;70:349-60.
4
ABC of breast diseases: breast cancer.乳腺疾病基础知识：乳腺癌
BMJ. 2000 Sep 23;321(7263):745-50. doi: 10.1136/bmj.321.7263.745.
5
Update: NCCN breast cancer clinical practice guidelines.更新：美国国立综合癌症网络（NCCN）乳腺癌临床实践指南。
J Natl Compr Canc Netw. 2004 Sep;2 Suppl 3:S-1-4.
6
Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys.筛查对浸润性乳腺癌临床病理特征及治疗的影响：两项全国性调查结果
Cancer Radiother. 2015 Aug;19(5):295-302. doi: 10.1016/j.canrad.2015.02.015. Epub 2015 Jul 15.
7
Breast Cancer Staging Working Group report.
J Magn Reson Imaging. 1999 Dec;10(6):991-4. doi: 10.1002/(sici)1522-2586(199912)10:6<991::aid-jmri16>3.0.co;2-3.
8
Neoadjuvant chemotherapy in breast cancers.乳腺癌的新辅助化疗
Womens Health (Lond). 2016 Sep;12(5):480-491. doi: 10.1177/1745505716677139.
9
Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.乳腺浸润性小叶癌与浸润性导管癌辅助化疗的相对疗效
Cancer. 2017 Aug 15;123(16):3015-3021. doi: 10.1002/cncr.30699. Epub 2017 Apr 5.
10
Immediate reconstruction after neoadjuvant chemotherapy: effect on adjuvant treatment starting and survival.新辅助化疗后立即重建：对辅助治疗开始及生存的影响
Ann Surg Oncol. 2005 Feb;12(2):161-6. doi: 10.1245/ASO.2005.04.003. Epub 2005 Feb 4.

引用本文的文献

1
A systematic review of patient-reported outcome measures (PROMs) to assess health-related quality of life (HRQoL) for breast cancer patients who are undertaking adjuvant endocrine therapy.一项关于患者报告结局指标（PROMs）的系统评价，以评估接受辅助内分泌治疗的乳腺癌患者的健康相关生活质量（HRQoL）。
Qual Life Res. 2025 Jun 18. doi: 10.1007/s11136-025-04004-y.
2
Mapping immune cell dynamics and macrophage plasticity in breast cancer tumor microenvironment through single-cell analysis.通过单细胞分析绘制乳腺癌肿瘤微环境中的免疫细胞动态变化及巨噬细胞可塑性
Discov Oncol. 2025 Apr 28;16(1):625. doi: 10.1007/s12672-025-02419-0.
3
Predictors of Unilateral Arm Lymphedema in Non-obese Locoregionally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy, Modified Radical Mastectomy, and Postoperative Irradiation.
接受新辅助化疗、改良根治性乳房切除术及术后放疗的非肥胖局部晚期乳腺癌患者单侧手臂淋巴水肿的预测因素
Eur J Breast Health. 2024 Apr 1;20(2):149-155. doi: 10.4274/ejbh.galenos.2024.2024-1-11. eCollection 2024 Apr.
4
A new prognostic model including immune biomarkers, genomic proliferation tumor markers ( and ) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients.一种新的预后模型，包括免疫生物标志物、基因组增殖肿瘤标志物以及临床病理特征，可优化新辅助乳腺癌患者的预后。 （注：原文中“genomic proliferation tumor markers ( and )”表述有误，括号里不应是“and”，这里按正确理解翻译）
Front Oncol. 2023 May 29;13:1182725. doi: 10.3389/fonc.2023.1182725. eCollection 2023.
5
Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin.蛋白磷酸酶2A的癌性抑制剂增强胃癌细胞对奥沙利铂的化疗耐药性。
World J Gastrointest Oncol. 2023 Feb 15;15(2):286-302. doi: 10.4251/wjgo.v15.i2.286.
6
Synchronous gastric cancer complicated with chronic myeloid leukemia (multiple primary cancers): A case report.同步性胃癌合并慢性髓系白血病（多原发性癌）：一例报告
World J Clin Cases. 2022 Oct 26;10(30):11146-11154. doi: 10.12998/wjcc.v10.i30.11146.
7
The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer.18F-FDG 正电子发射断层扫描在转移性乳腺癌纵隔淋巴结检测中的应用。
Breast. 2020 Dec;54:197-202. doi: 10.1016/j.breast.2020.10.011. Epub 2020 Oct 26.
8
F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer.氟维司群 PET 显像在唑来膦酸治疗 ER+/HER2-转移性乳腺癌以恢复内分泌敏感性的 II 期试验中。
J Nucl Med. 2021 Feb;62(2):184-190. doi: 10.2967/jnumed.120.244459. Epub 2020 Jun 26.
9
Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy.miR-139-5p在癌症诊断、预后及治疗中的潜在作用。
Oncol Lett. 2017 Aug;14(2):1215-1222. doi: 10.3892/ol.2017.6351. Epub 2017 Jun 8.
10
Leupaxin is expressed in mammary carcinoma and acts as a transcriptional activator of the estrogen receptor α.白细胞整合素结合蛋白在乳腺癌中表达，并作为雌激素受体α的转录激活因子发挥作用。
Int J Oncol. 2015 Jul;47(1):106-14. doi: 10.3892/ijo.2015.2988. Epub 2015 May 6.